STTK Q4 2021 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+2141.3% YoY

Gross Profit

$14M46.1% margin

Operating Income

$9M30.7% margin

Net Income

$8M26.1% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+1483.1%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$299M

Total Liabilities

$27M

Stockholders' Equity

$272M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$1M	+2141.3%
Gross Profit	$14M	-$8M	+264.3%
Operating Income	$9M	-$12M	+177.0%
Net Income	$8M	-$12M	+165.3%